|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/496 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Patento numeris | 4243825 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21820408.9 |
| Europos patento paraiškos padavimo data | 2021-11-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-09-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-11-12 |
| (46) | Apibrėžties vertimo paskelbimo data | 2026-01-12 |
| (86) | Numeris | PCT/US2021/058988 |
| Data | 2021-11-11 |
| (87) | Numeris | WO 2022/103966 |
| Data | 2022-05-19 |
| (30) | Numeris | Data | Šalis |
| 202063112995 P | 2020-11-12 | US | |
| 202163154077 P | 2021-02-26 | US | |
| 202163187084 P | 2021-05-11 | US | |
| 202163202873 P | 2021-06-28 | US | |
| 202163203436 P | 2021-07-22 | US |
| (72) |
HONARPOUR, Narimon , US
MALIK, Fady , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320,
US
Cytokinetics, Inc. , 350 Oyster Point Blvd, South San Francisco CA 94080, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Omekamtivo mekarbilis, skirtas širdies nepakankamumo gydymui pasirinktose pacientų grupėse |
| OMECAMTIV MECARBIL FOR THE TREATMENT OF HEART FAILURE IN SELECTED PATIENT GROUPS |